Werbung
NuVasive Aktie Analyse
31.10.18 | NuVasive Buy | Needham & Company, LLC | |
17.10.18 | NuVasive Buy | Needham & Company, LLC | |
27.09.18 | NuVasive Outperform | Robert W. Baird & Co. Incorporated | |
01.08.18 | NuVasive Buy | Needham & Company, LLC | |
04.05.18 | NuVasive Market Perform | BMO Capital Markets | |
02.05.18 | NuVasive Buy | Needham & Company, LLC | |
27.02.18 | NuVasive Buy | Needham & Company, LLC | |
04.01.18 | NuVasive Buy | Needham & Company, LLC | |
Werbung
|
|||
10.11.17 | NuVasive Outperform | RBC Capital Markets | |
25.10.17 | NuVasive Buy | Canaccord Adams | |
07.09.17 | NuVasive Buy | BTIG Research | |
06.06.17 | NuVasive Outperform | RBC Capital Markets | |
27.05.16 | NuVasive overweight | Barclays Capital | |
09.10.15 | NuVasive Outperform | BMO Capital Markets | |
06.10.15 | NuVasive Buy | Canaccord Adams | |
29.07.15 | NuVasive Outperform | Northland Capital | |
25.02.15 | NuVasive Buy | Brean Capital | |
13.01.15 | NuVasive Buy | WallachBeth | |
08.01.15 | NuVasive Outperform | RBC Capital Markets | |
04.12.14 | NuVasive Buy | Brean Capital | |
30.09.14 | NuVasive Buy | Brean Capital | |
30.07.12 | NuVasive outperform | Barrington Research | |
24.07.12 | NuVasive outperform | RBC Capital Markets | |
09.05.12 | NuVasive overweight | Barclays Capital | |
02.05.12 | NuVasive overweight | Barclays Capital | |
01.03.12 | NuVasive outperform | Barrington Research | |
24.02.12 | NuVasive overweight | Barclays Capital | |
27.01.12 | NuVasive overweight | Barclays Capital | |
18.01.12 | NuVasive overweight | Barclays Capital | |
31.10.11 | NuVasive overweight | Barclays Capital | |
03.10.11 | NuVasive outperform | Barrington Research | |
26.09.11 | NuVasive overweight | Barclays Capital | |
11.05.10 | NuVasive stark kaufen | Needham & Company, LLC | |
28.11.06 | NuVasive Outperform | Wachovia Sec | |
16.10.06 | NuVasive Overweight | Morgan Stanley | |
02.08.06 | NuVasive Overweight | Lehman Brothers |
Werbung